基于单核酸多态性的阿片类止痛药的个性化使用情况对照研究
Jing Yang1,2, Lei Zheng1, Fu Zheng2
1Department of Pharmacy, Shandong Provincial Third Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.
Frontiers in pharmacology
|August 28, 2025
概括
在服用阿片类止痛药的患者中,OPRM1的遗传变异与药物不良反应 (ADR) 的增加有关. 需要个性化药物治疗策略,特别是对于OPRM1AA基因型携带者,以提高安全性和有效性.
科学领域:
- 药物基因组学
- 临床药理学
- 遗传学
背景情况:
- 阿片类止痛药被广泛用于治疗疼痛.
- 基因多态性可以影响药物的疗效和不良反应 (ADR).
- 个性化药物治疗方法对于优化阿片类药物治疗至关重要.
研究的目的:
- 研究基因多态与阿片类止痛药的疗效和副作用之间的关联.
- 提高药物安全性,促进个性化治疗策略.
- 确定预测ADR风险和指导剂量的特定基因变异.
主要方法:
- 基于证据的药物的系统审查,以确定相关的基因位置.
- 涉及480名患者的病例控制研究,分为副作用和剂量需求组.
- 用SPSS和SNPStats进行目标基因 (CYP2D6,CYP3A5*3,ABCB1,OPRM1) 的基因定型和统计分析.
主要成果:
- 在OPRM1 (rs1799971,A>G) AA基因型和ADR发生率增加之间发现了显著的关联 (P < 0. 05).
- 与对照组相比,OPRM1 AA基因型的患者在ADR观察组中的比例更高.
- 在剂量需求方面没有发现基因型分布的显著差异,但ABCB1 (rs1045642,C>T) 需要进一步调查.
结论:
- OPRM1 AA基因型与阿片类止痛药副作用的风险较高有关.
- 患有OPRM1AA基因型的患者需要仔细监测副作用和可能较低的初始剂量.
- 需要在更大的群体中进行进一步的研究,以确认基因多态性与阿片类药物剂量需求之间的关联,重点是ABCB1基因.
相关概念视频
Analgesia and Pain Management
788
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
788
Opioid Analgesics: Morphine and Other Natural Cogeners
361
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
361
Opioid Analgesics: Synthetic and Semisynthetic Opioids
421
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
421
Single Nucleotide Polymorphisms-SNPs
15.8K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
15.8K
Genome-wide Association Studies-GWAS
14.1K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
14.1K
Opioid Receptors: Overview
1.8K
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
1.8K


